Cabaletta Bio Inc (CABA)
12.34
-0.28
(-2.22%)
USD |
NASDAQ |
May 17, 16:00
12.67
+0.33
(+2.67%)
After-Hours: 20:00
Cabaletta Bio Shareholders Equity (Quarterly): 221.72M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 221.72M |
| December 31, 2023 | 236.20M |
| September 30, 2023 | 160.92M |
| June 30, 2023 | 174.14M |
| March 31, 2023 | 91.65M |
| December 31, 2022 | 104.52M |
| September 30, 2022 | 85.87M |
| June 30, 2022 | 95.53M |
| March 31, 2022 | 106.72M |
| December 31, 2021 | 117.96M |
| September 30, 2021 | 116.62M |
| Date | Value |
|---|---|
| June 30, 2021 | 101.33M |
| March 31, 2021 | 103.31M |
| December 31, 2020 | 109.54M |
| September 30, 2020 | 117.50M |
| June 30, 2020 | 124.64M |
| March 31, 2020 | 131.71M |
| December 31, 2019 | 138.32M |
| September 30, 2019 | -26.08M |
| June 30, 2019 | 75.96M |
| December 31, 2018 | -10.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-26.08M
Minimum
Sep 2019
236.20M
Maximum
Dec 2023
119.40M
Average
113.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Editas Medicine Inc | 294.40M |
| ACADIA Pharmaceuticals Inc | 464.04M |
| Alnylam Pharmaceuticals Inc | -219.27M |
| Regeneron Pharmaceuticals Inc | 26.99B |
| Vertex Pharmaceuticals Inc | 18.55B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.46M |
| Total Liabilities (Quarterly) | 18.74M |